학술논문

Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
Document Type
Short Communication
Source
In Journal of Thoracic Oncology January 2021 16(1):162-168
Subject
Language
ISSN
1556-0864